Skip to content

Media & Press

In recent years, a significant shift has occurred in the healthcare landscape, marked by the rise of direct-to-consumer genetic testing. This trend represents a departure from traditional healthcare models, empowering individuals to take proactive steps towards managing their health.

Panacea is a company that provides clinic-grade whole exome sequencing directly to consumers to help with preventative healthcare planning. Pulse 2.0 interviewed Panacea founder Dahlia Attia-King to learn more about the company.

In recent years, a significant shift has occurred in the healthcare landscape, marked by the rise of direct-to-consumer genetic testing. This trend represents a departure from traditional healthcare models, empowering individuals to take proactive steps towards managing their health.

Just as 23andMe, once direct-to-consumer (DTC) testing’s darling, faced a huge drop in share value and once hot startup LunaDNA was shuttering, Panacea was promoting its new DTC genetic testing service.

For this feature edition, we were joined by Dahlia Attia-King, the Founder of Panacea, a direct-to-consumer genetic company who is making testing more accessible to the public.

Join Anthony Amen on Health and Fitness Redefined as he sits down with Dahlia Attia-King, founder and CEO of Panacea. Dahlia's story is nothing short of inspiring—transitioning from a hopeful medical student to a leader in health tech, she has dedicated her career to making clinical genetic testing both accessible and affordable.

Join Erica Huss, longtime wellness industry expert and entrepreneur, as she shares what she’s learned from over the years from building brands and products, creating conversations and experiences, and on my own health journey.

Join us at "Business Owners Speak," featuring Dahlia Attia-King, Founder of Panacea. Panacea is transforming the landscape of preventative healthcare with its comprehensive genetic testing services.

In this enlightening episode of the Decentralized Opportunity Podcast, Wyatt and Tanner sit down with Dahlia Attia-King, founder of Panacea, a revolutionary at-home genetic exome test that identifies markers for various diseases.

A podcast show about entrepreneurship, motivation, leadership, experiences, life lessons and more. For audiences who love self improvement, authentic conversations and more.

Health and wellness coaches can now help people take control of their health in a different way—through genetic testing! People can identify disease risks and make informed healthcare decisions. Dahlia Attia-King discusses genetic testing options—whole exome and genome sequencing.

Hailey Reidhead interviews ladies who inspire, uplift, and help you feel seen in this journey of womanhood. Dahlia shares her story about how genetic testing saved her life, and why we should be empowered to get testing done.

Panacea is bringing WES to a broader audience and promoting the value of this data for disease prevention and making smarter lifestyle choices.

Whole Exome Sequencing, which has been inaccessible due to narrow medical guidelines and insurance denials, analyzes every currently-known human gene.

WES, which has been inaccessible due to narrow medical guidelines and insurance denials, analyzes every currently-known human gene in order to identify markers of disease, allowing users to proactively plan for their health in the long term.

Join Andrii Buvailo as he talks with Dahlia Attia-King, the founder and CEO of Panacea about the need for increased access and utilization of life-saving clinical genetic testing.

Panacea, the one-stop-shop for genetic health services, today announced its nationwide commercial availability.

The company is able to offer more accurate testing for a lower price.

A growing industry of genetic testing startups, like Florida-based Panacea, is looking to change that. And backers of WES argue that the relatively new tech- which did not exist two decades ago- could be the key to the future of medicine.

Panacea is revolutionizing genetic testing by making comprehensive tests affordable and accessible. Learn about their innovative approach and the potential implications for healthcare.

Whole Exome Sequencing, which has been inaccessible due to narrow medical guidelines and insurance denials, allows users to proactively plan for their health in the long term.

Nicole and Romi from Her Pursuit

In this episode, Nicole and Romi dive headfirst into product development. Learn how to develop the product that sells directly to your target audience.

Dahlia Attia-King cover

Join us as Panacea Founder and CEO, Dahlia Attia-King, explores the transformative potential of clinical genetic testing, and how Panacea is breaking down barriers and revolutionazing healthcare accessibility to empower individuals in taking control of their health with disease prevention.

Panacea and our CEO, Dahlia Attia-King, are featured in the February issue of Palm Beach Illustrated magazine. In this exclusive interview, Dahlia shares the inspiring story of how Panacea's Whole Exome Sequencing genetic testing saved her and her sister's lives.

Interview to Dahlia Attia-King, founder of Panacea, at Love & Live with Carol Riddick

Dahlia and Carol chat about genetic testing, with a focus on our Whole Exome Sequencing test (Dahlia's segment begins at min 1:08:49)

The Brooklyn Cafe TV Show

Dahlia interviews at The Brooklyn Cafe TV show hosted by Dawn & Freddy S.

Dahlia Attia-King at Creative Mornings, Palm Beach, in a talk for The Complex Road to Simplicity

Dahlia takes us on her journey of founding Panacea and pushing healthcare into a much needed era of modernization

Blond woman sitting on her bed checking her lap top and cell phone. Cover of the The Daily Drip Blog post.

Our thought-leading founder, Dahlia, explains how to get in control your health

Interview to Dahlia Attia-Kind, Founder of Panacea, at DNA Today

Dahlia interviews with DNA Today: A Genetics Podcast with Kira Dineen

Interview to Dahlia Attia-King, founder of Panacea, at Lasting Conversations with Heather Lockett

A deep and rich conversation about Dahlia’s passion for genetic testing and clinical Whole Exome Sequencing